KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Johnson & Johnson's Deferred Taxes rose 236444.44% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year increase of 21354.01%. This contributed to the annual value of -$2.2 billion for FY2024, which is 4794.95% up from last year.
  • As of Q3 2025, Johnson & Johnson's Deferred Taxes stood at $2.2 billion, which was up 236444.44% from $825.0 million recorded in Q2 2025.
  • Johnson & Johnson's Deferred Taxes' 5-year high stood at $2.2 billion during Q3 2025, with a 5-year trough of -$2.4 billion in Q4 2023.
  • Over the past 5 years, Johnson & Johnson's median Deferred Taxes value was -$695.0 million (recorded in 2024), while the average stood at -$273.8 million.
  • In the last 5 years, Johnson & Johnson's Deferred Taxes tumbled by 145185.19% in 2021 and then skyrocketed by 236444.44% in 2025.
  • Over the past 5 years, Johnson & Johnson's Deferred Taxes (Quarter) stood at -$1.9 billion in 2021, then skyrocketed by 50.72% to -$926.0 million in 2022, then tumbled by 160.48% to -$2.4 billion in 2023, then soared by 99.34% to -$16.0 million in 2024, then soared by 13962.5% to $2.2 billion in 2025.
  • Its Deferred Taxes was $2.2 billion in Q3 2025, compared to $825.0 million in Q2 2025 and $2.2 billion in Q1 2025.